NZD 0.02
(-4.76%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 1.28 Million NZD | 16.99% |
2022 | 1.09 Million NZD | 186.58% |
2021 | 383.21 Thousand NZD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 FY | 1.28 Million NZD | 16.99% |
2023 Q4 | 1.28 Million NZD | 0.0% |
2022 FY | 1.09 Million NZD | 186.58% |
2022 Q4 | 1.08 Million NZD | 0.0% |
2021 FY | 383.21 Thousand NZD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
AFT Pharmaceuticals Limited | 77.46 Million NZD | 98.341% |
Rua Bioscience Limited | 973.12 Thousand NZD | -32.025% |